ACTIVE

ELSEN PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

-75,1 k €

-114.3% YoY

Gross margin

5,7 k €

-99.3% YoY

Equity

499,6 k €

-12.9% YoY

Workforce

0,0 ETP

What does ELSEN PHARMA do?

ELSEN PHARMA is a Public limited company incorporated in 1992. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Yvoir.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0446.359.356

Incorporation

15/01/1992

Legal form

Public limited company

Registered office

Avenue François-de-Lhoneux 9
5530 Yvoir · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2025

Average workforce

0,0 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation 68203Rental and operating of own or leased real estate 68203Rental and operating of own or leased real estate

Joint committees (2)

Signals

Solid equity

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	5,7 k €	-99.3%	842,8 k €	+935%	81,4 k €	+16.2%	70 k €	-55.9%	158,8 k €	-12.4%	181,3 k €	+8.3%	167,4 k €	-27.0%	229,4 k €	+16.6%	196,8 k €	+41.7%	138,9 k €	+8.8%	127,7 k €	+265%	-77,5 k €	-152%	147,6 k €	+53.0%	96,5 k €	-11.5%	109 k €	+25.6%	86,8 k €	-15.8%	103,1 k €	+32.2%	78 k €	-32.4%	115,4 k €	-14.0%	134,1 k €
EBITDA	-2,1 k €	-100%	836,9 k €	+1094%	70,1 k €	+17.4%	59,7 k €	-56.3%	136,7 k €	-19.0%	168,8 k €	+7.0%	157,7 k €	-25.8%	212,5 k €	+10.9%	191,6 k €	+45.5%	131,7 k €	+38.1%	95,4 k €	+208%	-88 k €	-164%	138,5 k €	+56.0%	88,8 k €	+17.7%	75,4 k €	-1.4%	76,5 k €	-16.2%	91,3 k €	+33.6%	68,3 k €	-29.1%	96,4 k €	-17.5%	116,9 k €
Operating result	-69,7 k €	-109%	739,8 k €	+7451%	9,8 k €	+166%	-14,8 k €	-128%	52,5 k €	-30.3%	75,4 k €	+12.7%	66,9 k €	-47.2%	126,7 k €	-8.8%	139 k €	+176%	50,3 k €	+6412%	773 €	+100%	-204,8 k €	-494%	52 k €	+923%	5,1 k €	+159%	-8,6 k €	+79.5%	-42 k €	-53.0%	-27,4 k €	+23.0%	-35,6 k €	-140%	-14,8 k €	-207%	13,9 k €
Net result	-75,1 k €	-114%	525 k €	+13202%	3,9 k €	+118%	-21,4 k €	-181%	26,3 k €	-47.3%	49,9 k €	+47.2%	33,9 k €	-57.2%	79,2 k €	-33.5%	119 k €	+308%	29,2 k €	+240%	-20,8 k €	+90.8%	-226,3 k €	-711%	37 k €	+340%	-15,4 k €	+54.8%	-34,1 k €	+48.2%	-65,9 k €	-27.3%	-51,8 k €	+4.8%	-54,4 k €	-29.7%	-41,9 k €	-594%	-6 k €
Balance sheet
Equity	499,6 k €	-12.9%	573,8 k €	+19.8%	479,1 k €	-19.8%	597 k €	-20.7%	753,2 k €	-2.5%	772,4 k €	+6.9%	722,5 k €	+4.9%	688,6 k €	+23523%	-2,9 k €	+97.6%	-121,9 k €	+19.3%	-151,1 k €	-16.0%	-130,3 k €	-236%	96 k €	+62.8%	59 k €	-20.7%	74,4 k €	-31.4%	108,5 k €	-37.8%	174,4 k €	-22.9%	226,1 k €	-19.4%	280,5 k €	-13.0%	322,4 k €
Total assets	1,3 M €	-8.2%	1,4 M €	+78.8%	787 k €	-15.7%	933,8 k €	-10.0%	1 M €	+3.2%	1 M €	-1.7%	1 M €	+2.1%	1 M €	+175%	364,1 k €	-9.1%	400,6 k €	-22.9%	519,5 k €	-18.1%	634,1 k €	-26.1%	858,4 k €	+13.7%	755,3 k €	-9.1%	831,2 k €	-10.4%	928,1 k €	-12.4%	1,1 M €	-0.9%	1,1 M €	-5.7%	1,1 M €	-11.6%	1,3 M €
Cash	78,5 k €	-9.8%	87 k €	+190%	30 k €	+71.1%	17,5 k €	-39.2%	28,9 k €	+21.1%	23,8 k €	-21.6%	30,4 k €	+182%	10,8 k €	-64.4%	30,4 k €	+1133%	2,5 k €	-95.2%	51,1 k €	+10004%	506 €	-99.0%	51,7 k €	+406%	10,2 k €	-39.1%	16,8 k €	+48.6%	11,3 k €	+20.8%	9,4 k €	-31.7%	13,7 k €	+9.0%	12,6 k €	+126%	5,6 k €
Debts	555,7 k €	-7.7%	602,3 k €	+110%	287,1 k €	-8.6%	314,2 k €	+20.7%	260,4 k €	+25.7%	207,2 k €	-22.7%	268,2 k €	-2.8%	275,8 k €	-11.6%	312,1 k €	-31.9%	458,5 k €	-23.5%	599,5 k €	-13.0%	689 k €	+1.1%	681,8 k €	+12.0%	608,9 k €	-8.2%	663,4 k €	-7.8%	719,8 k €	-7.6%	779,1 k €	+6.6%	731,1 k €	-0.5%	734,6 k €	-11.8%	833,3 k €
Other
Workforce	0,0 ETP		0,0 ETP		–		–		–		–		–		–		–		–		–		–		–		–		–		–		–		0,0 ETP	-100%	0,1 ETP	-80.0%	0,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 21 ended

Active mandates

Isabelle Elsen

Director · since 09 août 2005

Active

Christian ELSEN

Managing director · since 15 septembre 2004

Active

Ghislaine PRÈVE CATHERINE

Director · since 15 septembre 2004

Active

Ended mandates

Christian ELSEN

Managing director · since 01 janvier 2022 · until 18 juin 2028

Ended

André Elsen

Director · since 21 juin 2016 · until 20 juin 2022

Ended

Catherine Preve

Director · since 21 juin 2016 · until 20 juin 2022

Ended

Christian Eslen

Managing director · since 21 juin 2016 · until 20 juin 2022

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	25/08/2026	29/09/2025	09/08/2024	24/07/2023	04/08/2022	24/01/2022
General meeting	20/06/2026	21/06/2025	15/06/2024	17/06/2023	18/06/2022	19/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

20 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	20/06/2026	25/08/2026	French	PDF
Abridged model	31/12/2024	21/06/2025	29/09/2025	French	PDF
Micro model	31/12/2023	15/06/2024	09/08/2024	French	PDF
Micro model	31/12/2022	17/06/2023	24/07/2023	French	PDF
Micro model	31/12/2021	18/06/2022	04/08/2022	French	PDF
Micro model	31/12/2020	19/06/2021	24/01/2022	French	PDF
Micro model	31/12/2019	08/09/2020	30/10/2020	French	PDF
Micro model	31/12/2018	15/06/2019	30/08/2019	French	PDF
Micro model	31/12/2017	16/06/2018	26/09/2018	French	PDF
Micro model	31/12/2016	17/06/2017	04/10/2017	French	PDF
Abridged model	31/12/2015	18/06/2016	17/10/2016	French	PDF
Abridged model	31/12/2014	20/06/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	21/06/2014	30/07/2014	French	PDF
Abridged model	31/12/2012	15/06/2013	18/07/2013	French	PDF
Abridged model	31/12/2011	16/06/2012	17/07/2012	French	PDF
Abridged model	31/12/2010	18/06/2011	23/08/2011	French	PDF
Abridged model	31/12/2009	19/06/2010	30/09/2010	French	PDF
Abridged model	31/12/2008	20/06/2009	27/08/2009	French	PDF
Abridged model	31/12/2007	21/06/2008	22/08/2008	French	PDF
Abridged model	31/12/2006	21/06/2007	28/08/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 21 ended

Active mandates

Isabelle Elsen

Director · since 09 août 2005

Active

Christian ELSEN

Managing director · since 15 septembre 2004

Active

Ghislaine PRÈVE CATHERINE

Director · since 15 septembre 2004

Active

Ended mandates

Christian ELSEN

Managing director · since 01 janvier 2022 · until 18 juin 2028

Ended

André Elsen

Director · since 21 juin 2016 · until 20 juin 2022

Ended

Catherine Preve

Director · since 21 juin 2016 · until 20 juin 2022

Ended

Christian Eslen

Managing director · since 21 juin 2016 · until 20 juin 2022

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates05/09/2022
DEMISSIONS, NOMINATIONS
PDF
Mandates31/10/2017
DEMISSIONS, NOMINATIONS
PDF
Mandates13/04/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates25/10/2010
DEMISSIONS, NOMINATIONS
PDF
Mandates22/08/2005
DEMISSIONS, NOMINATIONS
PDF
Mandates01/10/2004
DENOMINATION - OBJET - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025-75,1 k €↓
2024
Annual accounts 2024525 k €↑
2023
Annual accounts 20233,9 k €↑
2022
Annual accounts 2022-21,4 k €↓
2021
Annual accounts 202126,3 k €↓
2020
Annual accounts 202049,9 k €↑
2019
Annual accounts 201933,9 k €↓
2018
Annual accounts 201879,2 k €↓
2017
Annual accounts 2017119 k €↑
2016
Annual accounts 201629,2 k €↑
2015
Annual accounts 2015-20,8 k €↑
2014
Annual accounts 2014-226,3 k €↓
2013
Annual accounts 201337 k €↑
2012
Annual accounts 2012-15,4 k €↑
2011
Annual accounts 2011-34,1 k €↑
2010
Annual accounts 2010-65,9 k €↓
2009
Annual accounts 2009-51,8 k €↑
2008
Annual accounts 2008-54,4 k €↓
2007
Annual accounts 2007-41,9 k €↓
2006
Annual accounts 2006-6 k €
15/01/1992
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

ELSEN PHARMA

Overview

What does ELSEN PHARMA do?

Trend over 20 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline